Prostaglandin D2 induces contraction via thromboxane A2 receptor in rat liver myofibroblasts

European Journal of Pharmacology

Volumn 591, Issue 1-3, 2008, Pages 237-242

  Maruyama, Tomoharu ^a   Murata, Takahisa ^a   Ayabe, Shinya ^a   Hori, Masatoshi ^a   Ozaki, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Contraction; Liver myofibroblast; Prostaglandin D2; Thromboxane A2 receptor

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; COLLAGEN GEL; LANTHANUM CHLORIDE; MESSENGER RNA; PROSTAGLANDIN D2; PROSTANOID RECEPTOR; PROSTANOID RECEPTOR AGONIST; RAMATROBAN; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOSE RESPONSE; FIBROBLAST CULTURE; LIVER CIRRHOSIS; LIVER MYOFIBROBLAST; MALE; MUSCLE CONTRACTION; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH2 CELL;

ANIMALS; CALCIUM; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GENE EXPRESSION REGULATION; LIVER; MALE; MUSCLE CONTRACTION; PROSTAGLANDIN D2; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 48749088631     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.06.037     Document Type: Article

References (36)

1. Beasley R.C., Featherstone R.L., Church M.K., Rafferty P., Varley J.G., Harris A., Robinson C., and Holgate S.T. Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. J. Appl. Physiol. 66 (1989) 1685-1693
2. Bhathal P.S., and Grossman H.J. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J. Hepatol. 1 (1985) 325-337
3. Boie Y., Sawyer N., Slipetz D.M., Metters K.M., and Abramovitz M. Molecular cloning and characterization of the human prostanoid DP receptor. J. Biol. Chem. 270 (1995) 18910-18916
4. Bosch J., and Garcia-Pagan J.C. Complications of cirrhosisI. Portal hypertension. J. Hepatol. 32 (2000) 141-156
5. Cheng J., Imanishi H., Iijima H., Shimomura S., Yamamoto T., Amuro Y., Kubota A., and Hada T. Expression of cyclooxygenase 2 and cytosolic phospholipase A(2) in the liver tissue of patients with chronic hepatitis and liver cirrhosis. Hepatol. Res. 23 (2002) 185-195
6. Claria J. Cyclooxygenase-2 biology. Curr. Pharm. Des. 9 (2003) 2177-2190
7. Coleman R.A., and Sheldrick R.L. Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors. Br. J. Pharmacol. 96 (1989) 688-692
8. Crofford L.J. COX-1 and COX-2 tissue expression: implications and predictions. J. Rheumatol. Suppl. 49 (1997) 15-19
9. de Leeuw A.M., McCarthy S.P., Geerts A., and Knook D.L. Purified rat liver fat-storing cells in culture divide and contain collagen. Hepatology 4 (1984) 392-403
10. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192 (1990) 245-261
11. Fennekohl A., Schieferdecker H.L., Jungermann K., and Puschel G.P. Differential expression of prostanoid receptors in hepatocytes, Kupffer cells, sinusoidal endothelial cells and stellate cells of rat liver. J. Hepatol. 30 (1999) 38-47
12. Gallois C., Habib A., Tao J., Moulin S., Maclouf J., Mallat A., and Lotersztajn S. Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2. J. Biol. Chem. 273 (1998) 23183-23190
13. Herlong J.L., and Scott T.R. Positioning prostanoids of the D and J series in the immunopathogenic scheme. Immunol. Lett. 102 (2006) 121-131
14. Huang J.S., Ramamurthy S.K., Lin X., and Le Breton G.C. Cell signalling through thromboxane A2 receptors. Cell. Signal. 16 (2004) 521-533
15. Kawada N., Klein H., and Decker K. Eicosanoid-mediated contractility of hepatic stellate cells. Biochem. J. 285 Pt 2 (1992) 367-371
16. Kawada N., Tran-Thi T.A., Klein H., and Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur. J. Biochem. 213 (1993) 815-823
17. Kinnman N., Francoz C., Barbu V., Wendum D., Rey C., Hultcrantz R., Poupon R., and Housset C. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab. Invest. 83 (2003) 163-173
18. Knittel T., Kobold D., Saile B., Grundmann A., Neubauer K., Piscaglia F., and Ramadori G. Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 117 (1999) 1205-1221
19. Kohyama T., Wyatt T.A., Liu X., Wen F.Q., Kobayashi T., Fang Q., Kim H.J., and Rennard S.I. PGD(2) modulates fibroblast-mediated native collagen gel contraction. Am. J. Respir. Cell. Mol. Biol. 27 (2002) 375-381
20. Kojima N., Hori M., Murata T., Morizane Y., and Ozaki H. Different profiles of Ca2+ responses to endothelin-1 and PDGF in liver myofibroblasts during the process of cell differentiation. Br. J. Pharmacol. 151 (2007) 816-827
21. Kostenis E., and Ulven T. Emerging roles of DP and CRTH2 in allergic inflammation. Trends. Mol. Med. 12 (2006) 148-158
22. Kroll B., Kunz S., Klein T., and Schwarz L.R. Effect of lindane and phenobarbital on cyclooxygenase-2 expression and prostanoid synthesis by Kupffer cells. Carcinogenesis 20 (1999) 1411-1416
23. Liu X.D., Skold M., Umino T., Zhu Y.K., Romberger D.J., Spurzem J.R., and Rennard S.I. Endothelial cell-mediated type I collagen gel contraction is regulated by hemin. J. Lab. Clin. Med. 136 (2000) 100-109
24. Mohammed N.A., Abd El-Aleem S.A., El-Hafiz H.A., and McMahon R.F. Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis. J. Clin. Pathol. 57 (2004) 350-354
25. Nanji A.A., Miao L., Thomas P., Rahemtulla A., Khwaja S., Zhao S., Peters D., Tahan S.R., and Dannenberg A.J. Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology. 112 (1997) 943-951
26. Nanji A.A., Zakim D., Rahemtulla A., Daly T., Miao L., Zhao S., Khwaja S., Tahan S.R., and Dannenberg A.J. Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatology 26 (1997) 1538-1545
27. Nunez O., Fernandez-Martinez A., Majano P.L., Apolinario A., Gomez-Gonzalo M., Benedicto I., Lopez-Cabrera M., Bosca L., Clemente G., Garcia-Monzon C., and Martin-Sanz P. Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins. Gut 53 (2004) 1665-1672
28. Pettipher R., Hansel T.T., and Armer R. Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. Nat. Rev. Drug. Discov. 6 (2007) 313-325
29. Ramadori G., and Saile B. Mesenchymal cells in the liver-one cell type or two?. Liver 22 (2002) 283-294
30. Rockey D.C. Hepatic blood flow regulation by stellate cells in normal and injured liver. Semin. Liver Dis. 21 (2001) 337-349
31. Saile B., Matthes N., Neubauer K., Eisenbach C., El-Armouche H., Dudas J., and Ramadori G. Rat liver myofibroblasts and hepatic stellate cells differ in CD95-mediated apoptosis and response to TNF-alpha. Am. J. Physiol. Gastrointest. Liver Physiol. 283 (2002) G435-444
32. Steib C.J., Gerbes A.L., Bystron M., Op den Winkel M., Hartl J., Roggel F., Prufer T., Goke B., and Bilzer M. Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2). J. Hepatol. 47 (2007) 228-238
33. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 97-120
34. Xue L., Gyles S.L., Wettey F.R., Gazi L., Townsend E., Hunter M.G., and Pettipher R. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J. Immunol. 175 (2005) 6531-6536
35. Yin H., Cheng L., Langenbach R., and Ju C. Prostaglandin I(2) and E(2) mediate the protective effects of cyclooxygenase-2 in a mouse model of immune-mediated liver injury. Hepatology 45 (2007) 159-169
36. Zhang F., Warskulat U., Wettstein M., Schreiber R., Henninger H.P., Decker K., and Haussinger D. Hyperosmolarity stimulates prostaglandin synthesis and cyclooxygenase-2 expression in activated rat liver macrophages. Biochem. J. 312 Pt 1 (1995) 135-143